Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Direct antivirals"'
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in immunocompromised patients and after congenital infection. There are currently drugs available to treat HCMV infection, targeting viral polymerase, whose use is compli
Externí odkaz:
https://doaj.org/article/ddae6341ee44403e8a1aaf5e2b663f6d
Autor:
A. I. Gubenko, N. N. Eremenko
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 9, Iss 1, Pp 6-13 (2019)
In 2016 the WHO Assembly defined a global strategy to combat viral hepatitis viruses, which seeks to eliminate these infections by 2030. The most important goals of this programme, adopted by 194 countries, are to reduce the incidence of viral hepati
Externí odkaz:
https://doaj.org/article/b38d2e9be253417e8ab13957237f656d
Autor:
CUCIUREANU, Tudor, Trifan, Anca, STANCIU, Carol, CHIRIAC, Stefan, SFARTI, Catalin, MUZICA, Cristina Maria, SINGEAP, Ana Maria, MIFTODE, Larisa, HUIBAN, Laura
Publikováno v:
Revista de Cercetare şi Intervenţie Socială / Review of Research and Social Intervention. (60):65-78
Externí odkaz:
https://www.ceeol.com/search/article-detail?id=637503
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
e_Buah Biblioteca Digital Universidad de Alcalá
instname
instname
El presente artículo es una revisión sobre el tratamiento del VHC en pacientes infectados por el VIH. Se aborda brevemente el contexto epidemiológico, la interacción existente entre ambos virus, y la historia natural e inmunopatogenia del VHC. Po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d365976423b5b1c85f99bd9d764cdf
https://hdl.handle.net/10017/40232
https://hdl.handle.net/10017/40232
Autor:
Goran Bjelakovic, Janus Christian Jakobsen, M. Bjelakovic, Goran Hauser, Ronald L. Koretz, Goran Poropat, Christian Gluud, Snezana Djurisic
Publikováno v:
The American journal of gastroenterology
Volume 10.1038/s41395-018-0029-4
Issue 10.1038/s41395-018-0029-4
Volume 10.1038/s41395-018-0029-4
Issue 10.1038/s41395-018-0029-4
Odgovor na prethodno objavljee primjedbe na naš rad
Autor:
Pierre Nahon, Valérie Bourcier, Richard Layese, Etienne Audureau, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Hélène Fontaine, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Vincent Leroy, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Sébastien Dharancy, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Brigitte Bernard-Chabert, David Zucman, Vincent Di Martino, Vincent Thibaut, Dominique Salmon, Marianne Ziol, Angela Sutton, Stanislas Pol, Françoise Roudot-Thoraval, Gérard Thiefin, Sophie Hillaire
Publikováno v:
Gastroenterology
Gastroenterology, Elsevier, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Gastroenterology, WB Saunders, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Gastroenterology, 2017, 152, pp.142-156.e2. 〈10.1053/j.gastro.2016.09.009〉
Gastroenterology, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Gastroenterology, Elsevier, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Gastroenterology, WB Saunders, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Gastroenterology, 2017, 152, pp.142-156.e2. 〈10.1053/j.gastro.2016.09.009〉
Gastroenterology, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
International audience; BACKGROUND & AIMS: We performed a prospective study to investigate the effects of a sustained viral response (SVR) on outcomes of patients with hepatitis C virus (HCV) infection and compensated cirrhosis. METHODS: We collected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e2d50c9d0be11a8b37eec97f54374e
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01447065
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01447065
Autor:
Kiran Kumar Katakam, Snezana Djurisic, Joshua Feinberg, Kristina Fobian, M. Bjelakovic, Ronald L. Koretz, Emil Eik Nielsen, Karl Heinz Weiss, Dimitrinka Nikolova, Christian Gluud, Goran Bjelakovic, Janus Christian Jakobsen, Jianping Liu, Goran Poropat, Goran Hauser, Sarah Louise Klingenberg
Publikováno v:
Cochrane database of systematic reviews
Volume 9
Jakobsen, J C, Nielsen, E E, Feinberg, J, Katakam, K K, Fobian, K, Hauser, G, Poropat, G, Djurisic, S, Weiss, K H, Bjelakovic, M, Bjelakovic, G, Klingenberg, S L, Liu, J P, Nikolova, D, Koretz, R L & Gluud, C 2017, ' Direct-acting antivirals for chronic hepatitis C ', Cochrane Database of Systematic Reviews, vol. 2017, no. 6, CD012143 . https://doi.org/10.1002/14651858.CD012143.pub3
ResearcherID
The Cochrane Library
Volume 9
Jakobsen, J C, Nielsen, E E, Feinberg, J, Katakam, K K, Fobian, K, Hauser, G, Poropat, G, Djurisic, S, Weiss, K H, Bjelakovic, M, Bjelakovic, G, Klingenberg, S L, Liu, J P, Nikolova, D, Koretz, R L & Gluud, C 2017, ' Direct-acting antivirals for chronic hepatitis C ', Cochrane Database of Systematic Reviews, vol. 2017, no. 6, CD012143 . https://doi.org/10.1002/14651858.CD012143.pub3
ResearcherID
The Cochrane Library
BACKGROUND: Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct-acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive interventions for chronic hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ec408e588b3556c60a0ec4b7aaed25
https://www.bib.irb.hr/931057
https://www.bib.irb.hr/931057
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical and Translational Hepatology
Hepatitis C virus (HCV) infection is a growing public health concern, with 184 million people infected worldwide. During the past decade, interferon has been the backbone of HCV treatment, even though it remains far from ideal. The latest development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55df3b05824c2863acfafa5a9e08020
https://hdl.handle.net/11380/1237234
https://hdl.handle.net/11380/1237234